We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERF
1401
DELISTED
Enerplus Corporation
ERF
$49K ﹤0.01%
6,200
TERP
1402
DELISTED
TerraForm Power, Inc
TERP
$49K ﹤0.01%
+4,000
New +$48.3K
VSTO
1403
DELISTED
Vista Outdoor Inc.
VSTO
$49K ﹤0.01%
2,420
ADAP
1404
DELISTED
Adaptimmune Therapeutics
ADAP
$48K ﹤0.01%
8,823
CMP icon
1405
Compass Minerals
CMP
$1.25B
$48K ﹤0.01%
718
+644
+870% +$49.1K
B
1406
Barrick Mining
B
$62.6B
$48K ﹤0.01%
2,611
-42
-2% -$775
IVOO icon
1407
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.74B
$48K ﹤0.01%
842
STM icon
1408
STMicroelectronics
STM
$47.7B
$48K ﹤0.01%
3,155
+2,104
+200% +$29.3K
X
1409
DELISTED
US Steel
X
$48K ﹤0.01%
1,440
+1,040
+260% +$37K
XLG icon
1410
Invesco S&P 500 Top 50 ETF
XLG
$10.4B
$48K ﹤0.01%
2,900
MDR
1411
DELISTED
McDermott International
MDR
$48K ﹤0.01%
2,377
+82
+4% +$1.81K
KNBWY
1412
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
$48K ﹤0.01%
2,597
+1,427
+122% +$26.4K
ARMK icon
1413
Aramark
ARMK
$15.2B
$47K ﹤0.01%
1,782
-13,941
-89% -$355K
CMT icon
1414
Core Molding Technologies
CMT
$208M
$47K ﹤0.01%
2,650
EPAY
1415
DELISTED
Bottomline Technologies Inc
EPAY
$47K ﹤0.01%
2,011
+136
+7% +$3.43K
DDD icon
1416
3D Systems Corp
DDD
$430M
$46K ﹤0.01%
3,131
+2,000
+177% +$31.4K
E icon
1417
ENI
E
$73.5B
$46K ﹤0.01%
1,431
-222
-13% -$7.04K
FXA icon
1418
Invesco CurrencyShares Australian Dollar Trust
FXA
$97M
$46K ﹤0.01%
+605
New +$45.9K
IYR icon
1419
iShares US Real Estate ETF
IYR
$4.73B
$46K ﹤0.01%
594
-609
-51% -$47.5K
KT icon
1420
KT
KT
$8.92B
$46K ﹤0.01%
2,816
+473
+20% +$7.32K
PBT
1421
Permian Basin Royalty Trust
PBT
$1.29B
$46K ﹤0.01%
5,000
PRO
1422
DELISTED
PROS Holdings
PRO
$46K ﹤0.01%
1,925
ROL icon
1423
Rollins
ROL
$18.8B
$46K ﹤0.01%
2,813
EGOV
1424
DELISTED
NIC Inc
EGOV
$46K ﹤0.01%
2,315
-23,648
-91% -$531K
TSRO
1425
DELISTED
TESARO, Inc.
TSRO
$46K ﹤0.01%
300

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.